Micromet to Present at the 28th Annual J.P. Morgan Healthcare Conference
08 January 2010 - 12:00AM
PR Newswire (US)
BETHESDA, Md., Jan. 7 /PRNewswire-FirstCall/ -- Micromet, Inc.
(NASDAQ: MITI) today announced that it will participate in the 28th
Annual J.P. Morgan Healthcare Conference, to be held January 11th -
14th in San Francisco. Christian Itin, Ph.D., Micromet's President
and CEO, will present a 30 minute corporate overview on Thursday,
January 14th at 12:30 PM PST. The presentation will be webcast live
and may be accessed by visiting the Micromet website at
http://www.micromet-inc.com/. A replay of the webcast will be
available for 90 days. About Micromet, Inc. Micromet, Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of innovative antibody-based therapies for the
treatment of cancer. Its product development pipeline includes
novel antibodies generated with its proprietary BiTEĀ® technology,
as well as conventional monoclonal antibodies. Two of Micromet's
BiTE antibodies and three of its conventional antibodies are
currently in clinical trials. Micromet has collaborations with a
number of leading pharmaceutical and biotechnology companies,
including sanofi-aventis, Bayer Schering Pharma, Merck Serono,
MedImmune and Nycomed. Additional information can be found at
http://www.micromet-inc.com/. DATASOURCE: Micromet, Inc. CONTACT:
Jennifer Neiman, Micromet, Inc., Director, Corporate
Communications, +1-240-235-0246, Web Site:
http://www.micromet-inc.com/
Copyright